Fig. 2
From: Impact of a two step antimicrobial stewardship program in a paediatric haematology and oncology unit
Interrupted time series of monthly antimicrobial consumption for the Haematopoietic Stem Cell Transplantation (HSCT) Unit (blue line) with reference monthly value and 95%CI (grey lines) for meropenem (A), piperacillin/tazobactam (B), third-generation cephalosporins (C), amikacin (D), glycopeptid€(E) and quinolones (F). Orange box refers to the period from the first intervention (febrile neutropenia protocol dissemination) and the second intervention (Antimicrobial Stewardship program, ASP). The green box refers to the post-ASP intervention.
